• Option Grids: information for melanoma patients

    NICE has worked with Option Grid and UK dermatologists Jason Thomson and Jane McGregor, to produce information for melanoma patients and their medical teams. The information is provided in the form of Option Grids which allow consideration of the potential advantages and disadvantages of given medical procedures or treatments.Read More
  • BAP1: a newly recognised melanoma gene

    GenoMEL has some new information in the Information for Patients section, on a rare inherited genetic mutation which increases the risk of melanoma in some families. The appearance of the moles and the melanomas in these families can be unusual and affected families are also at increased risk ofRead More
  • NICE Clinical Melanoma Guideline

    NICE published the Clinical Melanoma Guideline in July 2015. This Guideline is directed at secondary and tertiary care (hospital treatment) in the UK and considers the role of treatments such as sentinel node biopsy. This is a link to the guideline http://www.nice.org.uk/guidance/ng14 The Guideline addressed the role of sentinel nodeRead More
  • Vitamin D and melanoma: new podcast

    NICE asked Professor Julia Newton-Bishop to discuss why vitamin D was considered by the Clinical Melanoma Guideline and this is the link to her podcast  Read More
  • Plain language summaries of GenoMEL published papers

    We have updated the plain language summaries of GenoMEL research in the Information for Patients section. More to follow!Read More
  • New GenoMEL paper

    The Journal of the National Cancer Institute has published a new GenoMEL paper examining the role of chromosomal telomere length in melanoma. The research involved creating a score representing genetically determined telomere length, based on all the established telomere associated genes and found that this score correlated with melanomaRead More
  • Fellow of the Academy of Medical Sciences

    The consortium’s coordinator, Prof. Julia Newton Bishop, has been elected to theFellowship of the Academy of Medical Sciences. Academy Fellows are elected for excellence in medical research, innovative application of scientific knowledge or conspicuous service to healthcare. This prestigious award is recognition of Julia’s contribution to understanding melanoma genetics.Read More
  • 2015 meeting

    The last annual meeting was in Lund, Sweden in May 2015. At this meeting a new related training network was launched called MELGEN (see the MELGEN section of the web site). MELGEN is a Marie Curie training network funded by the EU Horizon 2020 in which 17 new PhDRead More

Julia Newton-Bishop, University of Leeds